Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Gene Therapy for CNS Disorders Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 bluebird bio, Inc.
  • 5.1.1 bluebird bio, Inc. Company Profile
  • 5.1.2 bluebird bio, Inc. Business Overview
  • 5.1.3 bluebird bio, Inc. Gene Therapy for CNS Disorders Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 bluebird bio, Inc. Gene Therapy for CNS Disorders Products Introduction
• 5.2 Novartis AG
  • 5.2.1 Novartis AG Company Profile
  • 5.2.2 Novartis AG Business Overview
  • 5.2.3 Novartis AG Gene Therapy for CNS Disorders Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 Novartis AG Gene Therapy for CNS Disorders Products Introduction
• 5.3 Biogen
  • 5.3.1 Biogen Company Profile
  • 5.3.2 Biogen Business Overview
  • 5.3.3 Biogen Gene Therapy for CNS Disorders Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Biogen Gene Therapy for CNS Disorders Products Introduction
• 5.4 Pfizer Inc.
  • 5.4.1 Pfizer Inc. Company Profile
  • 5.4.2 Pfizer Inc. Business Overview
  • 5.4.3 Pfizer Inc. Gene Therapy for CNS Disorders Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Pfizer Inc. Gene Therapy for CNS Disorders Products Introduction
• 5.5 Roche (Spark Therapeutics)
  • 5.5.1 Roche (Spark Therapeutics) Company Profile
  • 5.5.2 Roche (Spark Therapeutics) Business Overview
  • 5.5.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Products Introduction
• 5.6 Voyager Therapeutics
  • 5.6.1 Voyager Therapeutics Company Profile
  • 5.6.2 Voyager Therapeutics Business Overview
  • 5.6.3 Voyager Therapeutics Gene Therapy for CNS Disorders Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Voyager Therapeutics Gene Therapy for CNS Disorders Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Gene Therapy for CNS Disorders Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Gene Therapy for CNS Disorders Price by Types (2015-2020)
• 6.2 Global Gene Therapy for CNS Disorders Market Forecast by Types (2020-2025)
  • 6.2.1 Global Gene Therapy for CNS Disorders Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Gene Therapy for CNS Disorders Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Gene Therapy for CNS Disorders Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Gene Therapy for CNS Disorders Sales, Price and Growth Rate of AAV
  • 6.3.2 Global Gene Therapy for CNS Disorders Sales, Price and Growth Rate of Adenovirus
• 6.4 Global Gene Therapy for CNS Disorders Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 AAV Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Adenovirus Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Gene Therapy for CNS Disorders Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Gene Therapy for CNS Disorders Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Gene Therapy for CNS Disorders Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Gene Therapy for CNS Disorders Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Gene Therapy for CNS Disorders Revenue, Sales and Growth Rate of SMA (2015-2020)
  • 7.3.2 Global Gene Therapy for CNS Disorders Revenue, Sales and Growth Rate of Others (2015-2020)
• 7.4 Global Gene Therapy for CNS Disorders Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 SMA Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Gene Therapy for CNS Disorders Sales by Regions (2015-2020)
• 8.2 Global Gene Therapy for CNS Disorders Market Revenue by Regions (2015-2020)
• 8.3 Global Gene Therapy for CNS Disorders Market Forecast by Regions (2020-2025)

9 North America Gene Therapy for CNS Disorders Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)
• 9.3 North America Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Gene Therapy for CNS Disorders Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Gene Therapy for CNS Disorders Market Analysis by Country
  • 9.6.1 U.S. Gene Therapy for CNS Disorders Sales and Growth Rate
  • 9.6.2 Canada Gene Therapy for CNS Disorders Sales and Growth Rate
  • 9.6.3 Mexico Gene Therapy for CNS Disorders Sales and Growth Rate

10 Europe Gene Therapy for CNS Disorders Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Gene Therapy for CNS Disorders Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Gene Therapy for CNS Disorders Market Analysis by Country
  • 10.6.1 Germany Gene Therapy for CNS Disorders Sales and Growth Rate
  • 10.6.2 United Kingdom Gene Therapy for CNS Disorders Sales and Growth Rate
  • 10.6.3 France Gene Therapy for CNS Disorders Sales and Growth Rate
  • 10.6.4 Italy Gene Therapy for CNS Disorders Sales and Growth Rate
  • 10.6.5 Spain Gene Therapy for CNS Disorders Sales and Growth Rate
  • 10.6.6 Russia Gene Therapy for CNS Disorders Sales and Growth Rate

11 Asia-Pacific Gene Therapy for CNS Disorders Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Gene Therapy for CNS Disorders Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Gene Therapy for CNS Disorders Market Analysis by Country
  • 11.6.1 China Gene Therapy for CNS Disorders Sales and Growth Rate
  • 11.6.2 Japan Gene Therapy for CNS Disorders Sales and Growth Rate
  • 11.6.3 South Korea Gene Therapy for CNS Disorders Sales and Growth Rate
  • 11.6.4 Australia Gene Therapy for CNS Disorders Sales and Growth Rate
  • 11.6.5 India Gene Therapy for CNS Disorders Sales and Growth Rate

12 South America Gene Therapy for CNS Disorders Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)
• 12.3 South America Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Gene Therapy for CNS Disorders Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Gene Therapy for CNS Disorders Market Analysis by Country
  • 12.6.1 Brazil Gene Therapy for CNS Disorders Sales and Growth Rate
  • 12.6.2 Argentina Gene Therapy for CNS Disorders Sales and Growth Rate
  • 12.6.3 Columbia Gene Therapy for CNS Disorders Sales and Growth Rate

13 Middle East and Africa Gene Therapy for CNS Disorders Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Gene Therapy for CNS Disorders Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Gene Therapy for CNS Disorders Market Analysis by Country
  • 13.6.1 UAE Gene Therapy for CNS Disorders Sales and Growth Rate
  • 13.6.2 Egypt Gene Therapy for CNS Disorders Sales and Growth Rate
  • 13.6.3 South Africa Gene Therapy for CNS Disorders Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Gene Therapy for CNS Disorders Market Size and Growth Rate 2015-2025

Table Gene Therapy for CNS Disorders Key Market Segments

Figure Global Gene Therapy for CNS Disorders Market Revenue ($) Segment by Type from 2015-2020

Figure Global Gene Therapy for CNS Disorders Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Gene Therapy for CNS Disorders

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table bluebird bio, Inc. Company Profile

Table bluebird bio, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure bluebird bio, Inc. Production and Growth Rate

Figure bluebird bio, Inc. Market Revenue ($) Market Share 2015-2020

Table Novartis AG Company Profile

Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Novartis AG Production and Growth Rate

Figure Novartis AG Market Revenue ($) Market Share 2015-2020

Table Biogen Company Profile

Table Biogen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Biogen Production and Growth Rate

Figure Biogen Market Revenue ($) Market Share 2015-2020

Table Pfizer Inc. Company Profile

Table Pfizer Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Pfizer Inc. Production and Growth Rate

Figure Pfizer Inc. Market Revenue ($) Market Share 2015-2020

Table Roche (Spark Therapeutics) Company Profile

Table Roche (Spark Therapeutics) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Roche (Spark Therapeutics) Production and Growth Rate

Figure Roche (Spark Therapeutics) Market Revenue ($) Market Share 2015-2020

Table Voyager Therapeutics Company Profile

Table Voyager Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Voyager Therapeutics Production and Growth Rate

Figure Voyager Therapeutics Market Revenue ($) Market Share 2015-2020

Table Global Gene Therapy for CNS Disorders Sales by Types (2015-2020)

Table Global Gene Therapy for CNS Disorders Sales Share by Types (2015-2020)

Table Global Gene Therapy for CNS Disorders Revenue ($) by Types (2015-2020)

Table Global Gene Therapy for CNS Disorders Revenue Share by Types (2015-2020)

Table Global Gene Therapy for CNS Disorders Price ($) by Types (2015-2020)

Table Global Gene Therapy for CNS Disorders Market Forecast Sales by Types (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Sales Share by Types (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Revenue ($) by Types (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Revenue Share by Types (2020-2025)

Figure Global AAV Sales and Growth Rate (2015-2020)

Figure Global AAV Price (2015-2020)

Figure Global Adenovirus Sales and Growth Rate (2015-2020)

Figure Global Adenovirus Price (2015-2020)

Figure Global Gene Therapy for CNS Disorders Market Revenue ($) and Growth Rate Forecast of AAV (2020-2025)

Figure Global Gene Therapy for CNS Disorders Sales and Growth Rate Forecast of AAV (2020-2025)

Figure Global Gene Therapy for CNS Disorders Market Revenue ($) and Growth Rate Forecast of Adenovirus (2020-2025)

Figure Global Gene Therapy for CNS Disorders Sales and Growth Rate Forecast of Adenovirus (2020-2025)

Table Global Gene Therapy for CNS Disorders Sales by Applications (2015-2020)

Table Global Gene Therapy for CNS Disorders Sales Share by Applications (2015-2020)

Table Global Gene Therapy for CNS Disorders Revenue ($) by Applications (2015-2020)

Table Global Gene Therapy for CNS Disorders Revenue Share by Applications (2015-2020)

Table Global Gene Therapy for CNS Disorders Market Forecast Sales by Applications (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Sales Share by Applications (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Revenue Share by Applications (2020-2025)

Figure Global SMA Sales and Growth Rate (2015-2020)

Figure Global SMA Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global Gene Therapy for CNS Disorders Market Revenue ($) and Growth Rate Forecast of SMA (2020-2025)

Figure Global Gene Therapy for CNS Disorders Sales and Growth Rate Forecast of SMA (2020-2025)

Figure Global Gene Therapy for CNS Disorders Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global Gene Therapy for CNS Disorders Sales and Growth Rate Forecast of Others (2020-2025)

Figure Global Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020)

Table Global Gene Therapy for CNS Disorders Sales by Regions (2015-2020)

Table Global Gene Therapy for CNS Disorders Sales Market Share by Regions (2015-2020)

Figure Global Gene Therapy for CNS Disorders Sales Market Share by Regions in 2019

Figure Global Gene Therapy for CNS Disorders Revenue and Growth Rate (2015-2020)

Table Global Gene Therapy for CNS Disorders Revenue by Regions (2015-2020)

Table Global Gene Therapy for CNS Disorders Revenue Market Share by Regions (2015-2020)

Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Regions in 2019

Table Global Gene Therapy for CNS Disorders Market Forecast Sales by Regions (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Sales Share by Regions (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Gene Therapy for CNS Disorders Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure North America Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)

Figure North America Gene Therapy for CNS Disorders Market Forecast Sales (2020-2025)

Figure North America Gene Therapy for CNS Disorders Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Canada Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Mexico Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Europe Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Europe Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)

Figure Europe Gene Therapy for CNS Disorders Market Forecast Sales (2020-2025)

Figure Europe Gene Therapy for CNS Disorders Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure France Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Italy Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Spain Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Russia Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Gene Therapy for CNS Disorders Market Forecast Sales (2020-2025)

Figure Asia-Pacific Gene Therapy for CNS Disorders Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Japan Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure South Korea Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Australia Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure India Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure South America Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure South America Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)

Figure South America Gene Therapy for CNS Disorders Market Forecast Sales (2020-2025)

Figure South America Gene Therapy for CNS Disorders Market Forecast Revenue ($) (2020-2025)

Figure Brazil Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Argentina Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Columbia Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Gene Therapy for CNS Disorders Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Gene Therapy for CNS Disorders Market Forecast Sales (2020-2025)

Figure Middle East and Africa Gene Therapy for CNS Disorders Market Forecast Revenue ($) (2020-2025)

Figure UAE Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure Egypt Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Figure South Africa Gene Therapy for CNS Disorders Market Sales and Growth Rate (2015-2020)

Based on the Gene Therapy for CNS Disorders market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Gene Therapy for CNS Disorders market covered in Chapter 5:
bluebird bio, Inc.
Novartis AG
Biogen
Pfizer Inc.
Roche (Spark Therapeutics)
Voyager Therapeutics

In Chapter 6, on the basis of types, the Gene Therapy for CNS Disorders market from 2015 to 2025 is primarily split into:
AAV
Adenovirus

In Chapter 7, on the basis of applications, the Gene Therapy for CNS Disorders market from 2015 to 2025 covers:
SMA
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025